Clinical characteristics, disease activity, functional status, and quality of life results of patients with psoriatic arthritis using biological and conventional synthetic disease-modifying antirheumatic drugs

Creative Commons License

KESKİN Y., Nas K., Kilic E., Sargin B., Kasman S. A., ALKAN H., ...Daha Fazla

ARCHIVES OF RHEUMATOLOGY, cilt.36, sa.1, ss.1-9, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.46497/archrheumatol.2021.7874
  • Dergi Adı: ARCHIVES OF RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1-9
  • Anahtar Kelimeler: Disease-modifying antirheumatic drug, functional status, psoriatic arthritis, quality of life, ANKYLOSING-SPONDYLITIS, RECOMMENDATIONS, BATH, METHOTREXATE, PREVALENCE, INSTRUMENT, MANAGEMENT, ENTHESITIS, THERAPY, BURDEN
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Objectives: This study aims to compare the clinical characteristics, disease activity, and quality of life (QoL) of patients with psoriatic arthritis (PsA) who use biological and conventional synthetic disease-modifying antirheumatic drugs (DMARDs) in a nationwide cohort throughout Turkey.